{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:24Z","timestamp":1791319824646,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajg.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:55:40Z","timestamp":1791316540000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The use of anti-IL-5 in eosinophilic gastrointestinal disorders (EGIDs); a systematic review"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-4126","authenticated-orcid":false,"given":"Mohamed","family":"Elsaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-2510","authenticated-orcid":false,"given":"Mai Alaaeldin Temraz","family":"Elsebaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3003-4462","authenticated-orcid":false,"given":"Mayam Mohamed","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-0390","authenticated-orcid":false,"given":"Hadeer","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9555-1996","authenticated-orcid":false,"given":"Mohamed H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9524-7409","authenticated-orcid":false,"given":"Hamsa","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9825-4495","authenticated-orcid":false,"given":"Alaa","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2026.08.004_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaci.2003.10.047","article-title":"Eosinophilic gastrointestinal disorders (EGID)","volume":"113","author":"Rothenberg","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12016-019-08732-1","article-title":"Eosinophilic gastrointestinal disorders","volume":"57","author":"Gonsalves","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0015","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1136\/gutjnl-2023-329873","article-title":"Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis","volume":"72","author":"Visaggi","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.ajg.2026.08.004_bb0020","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/j.gastro.2014.07.055","article-title":"Advances in clinical management of eosinophilic esophagitis","volume":"147","author":"Dellon","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2026.08.004_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.dld.2021.10.004","article-title":"Older patients with eosinophilic esophagitis have high treatment response to topical steroids","volume":"54","author":"Ketchem","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajg.2026.08.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/11584340-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody","volume":"50","author":"Smith","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajg.2026.08.004_bb0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajg.2026.08.004_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/17474124.2024.2374471","article-title":"Eosinophilic esophagitis in the era of biologics","volume":"18","author":"Rossi","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajg.2026.08.004_bb0055","series-title":"RoB 2: A revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias","year":"2026"},{"key":"10.1016\/j.ajg.2026.08.004_bb0060","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa\u2019ad","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2026.08.004_bb0065","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jaip.2022.02.037","article-title":"Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic gastrointestinal disease","volume":"10","author":"Kuang","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ajg.2026.08.004_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.ajg.2026.08.004_bb0075","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1136\/gutjnl-2023-330337","article-title":"Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial","volume":"72","author":"Dellon","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.ajg.2026.08.004_bb0080","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/MPG.0000000000001840","article-title":"Safety and efficacy of Reslizumab for children and adolescents with Eosinophilic esophagitis treated for 9 years","volume":"66","author":"Markowitz","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ajg.2026.08.004_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mcna.2018.08.009","article-title":"Eosinophilic esophagitis","volume":"103","author":"Reed","year":"2019","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ajg.2026.08.004_bb0090","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2017.05.050","article-title":"Prevalence of Eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017","volume":"15","author":"Mansoor","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0095","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/ajg.2014.166","article-title":"Eosinophilic gastritis in children: clinicopathological correlation, disease course, and response to therapy","volume":"109","author":"Ko","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/ACI.0b013e328338cbab","article-title":"Food allergy and eosinophilic esophagitis","volume":"10","author":"Chehade","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.gtc.2014.02.007","article-title":"Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases","volume":"43","author":"Collins","year":"2014","journal-title":"Gastroenterol Clin"},{"key":"10.1016\/j.ajg.2026.08.004_bb0115","article-title":"Eosinophilic gastrointestinal disorders pathology","volume":"4","author":"Collins","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajg.2026.08.004_bb0120","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2026.08.004_bb0125","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.molcel.2015.01.026","article-title":"Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation","volume":"57","author":"Soragni","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajg.2026.08.004_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.24.021605.090720","article-title":"The eosinophil","volume":"24","author":"Rothenberg","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0135","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/his.12892","article-title":"Oesophageal intrasquamous IgG4 deposits: an adjunctive marker to distinguish eosinophilic oesophagitis from reflux oesophagitis","volume":"68","author":"Zukerberg","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.ajg.2026.08.004_bb0140","article-title":"CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference","volume":"38","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0145","article-title":"Eosinophilic gastrointestinal disorders pathology","volume":"4","author":"Collins","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajg.2026.08.004_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.815842","article-title":"Type 2 inflammation in eosinophilic esophagitis: from pathophysiology to therapeutic targets","volume":"12","author":"Racca","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajg.2026.08.004_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active Eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:55:45Z","timestamp":1791316545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S1687197926001127"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.08.004","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of anti-IL-5 in eosinophilic gastrointestinal disorders (EGIDs); a systematic review","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}